The Purina® Pro Plan® Breed Update newsletters cover the latest research advances in canine health and genetics for specific dog breeds, plus there is a general dog newsletter. Explore our archive of articles or use the filters to access specific information.
Most Rottweiler owners will agree no canine cancer is as scary as hemangiosarcoma (HSA). Challenging to diagnose and equally difficult to treat, HSA often renders a one-punch knockout when a tumor ruptures causing dogs to bleed to death internally.
An outgoing, friendly breed, the Labrador Retriever is often described as an ideal companion. Natural sporting dogs, Labradors glow with enthusiasm whether training for retrieving water blinds or a bumper thrown from a dock.
Osteosarcoma, or bone cancer, is a tough, complicated malignancy. No one knows exactly what causes osteosarcoma; however, large and giant breeds are considered to be at higher risk due to their size and weight.
As sentinels of breed health, parent clubs turn to dog breeders and owners to gather information. Their ability to understand the changing demographics of disease incidence is pivotal to breed improvement and sometimes even breed survival.
A fatal neurological disease affecting young Rottweiler dogs, juvenile-onset laryngeal paralysis and polyneuropathy (JLPP) is caused by an autosomal recessive mutation in the RAB3GAP1 gene. Affected dogs typically show signs of general weakness
Eye diseases in Poodles have long been a health concern. Despite efforts to encourage eye tests and advise breeders to selectively breed against eye diseases, one expert notes an ongoing steady increase in Poodle eye diseases.
Advances treating canine diseases, such as cancer, often come from innovative studies patterned after human medicine. New therapies using checkpoint molecules and personalized medicine for canine mast cell tumor provide a promising future.